ABVD versus Stanford V in Hodgkin Lymphoma


ABVD versus Stanford V in Hodgkin Lymphoma
Slides from a presentation at ASH 2010 and transcribed comments from a recent interview with Steven M Horwitz, MD (12/29/10)

Gordon LI et al. A randomized Phase III trial of ABVD vs Stanford V +/- radiation therapy in locally extensive and advanced stage Hodgkin’s lymphoma: An Intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496). Proc ASH 2010;Abstract 415.

Dr Horwitz is Assistant Attending in the Division of Hematologic Oncology’s Lymphoma Service at Memorial Sloan-Kettering Cancer Center in New York, New York.